marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2022-Q4
hinzugefügt 14.02.2023
Sio Gene Therapies Bilanz 2011-2024 | SIOX
Bilanz Jährlich Sio Gene Therapies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-118 M | -49.9 M | -62.8 M | -102 M | -161 M | -276 M | - | - | - | - | - |
Langfristige Schulden |
932 K | 15.4 M | 23 M | 42.9 M | 51.4 M | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
311 K | 889 K | 21.2 M | 9.75 M | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | 15.4 M | 23 M | 42.9 M | 51.4 M | - | 5 M | - | - | - | - |
Kurzfristige Verbindlichkeiten |
10.8 M | 32 M | 43.5 M | 46.6 M | 46.3 M | 15.8 M | - | - | - | - | - |
Gesamtverbindlichkeiten |
11.8 M | 32.1 M | 66.5 M | 89.5 M | 97.7 M | 15.8 M | 8.87 M | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-791 M | - | -686 M | -557 M | -335 M | -154 M | -21 M | - | - | - | - |
Vermögenswerte |
135 M | 93.7 M | 123 M | 161 M | 223 M | 282 M | 1.12 M | - | - | - | - |
Zahlungsmittel |
119 M | 80.8 M | 107 M | 154 M | 213 M | 276 M | - | - | - | - | - |
Buchwert |
123 M | 61.6 M | 56.2 M | 71.3 M | 125 M | 267 M | -7.75 M | - | - | - | - |
Gesamtes Eigenkapital |
123 M | 61.6 M | 56.2 M | 71.3 M | 125 M | 267 M | -7.75 M | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Sio Gene Therapies
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | 1.55 M | 1.73 M | 1.9 M | 865 K | 921 K | 932 K | 986 K | 55 K | 71 K | - | 6.45 M | 11.7 M | 17.5 M | 23 M | 28.3 M | 33.3 M | 38.2 M | 42.9 M | 47.6 M | 52.1 M | 51.8 M | 51.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
2.15 M | 4.83 M | 10.7 M | 14.7 M | 17 M | 11.2 M | 8.52 M | 11.8 M | 9.94 M | 10.1 M | 12.5 M | 32.1 M | 37.2 M | 59 M | 72.1 M | 66.5 M | 73.5 M | 82.3 M | 81.8 M | 89.5 M | 89.7 M | 93 M | 103 M | 97.7 M | 39.6 M | 28.6 M | 16.9 M | 15.8 M | 15.9 M | 10.4 M | 9.57 M | 8.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-878 M | -874 M | -871 M | -863 M | -850 M | -824 M | -803 M | -791 M | -788 M | -777 M | -767 M | -759 M | -742 M | -728 M | -714 M | -686 M | -677 M | -643 M | -609 M | -557 M | -532 M | -474 M | -405 M | -335 M | -282 M | -234 M | -192 M | -154 M | -125 M | -61.2 M | -49.1 M | -21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
47.3 M | 53.7 M | 62.5 M | 75.1 M | 93.3 M | 111 M | 122 M | 135 M | 99 M | 79.8 M | 71 M | 93.7 M | 42.3 M | 76.1 M | 101 M | 123 M | 96.2 M | 102 M | 108 M | 161 M | 196 M | 246 M | 309 M | 223 M | 206 M | 235 M | 257 M | 282 M | 304 M | 323 M | 331 M | 1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
46.1 M | 49.9 M | 54.8 M | 63.7 M | 81.9 M | 102 M | 111 M | 119 M | 81 M | 81 M | 63.2 M | 55.5 M | 27.8 M | 60.3 M | 84.2 M | 107 M | 84.9 M | 90.7 M | 90.7 M | 154 M | 188 M | 235 M | 298 M | 213 M | 200 M | 230 M | 253 M | 276 M | 300 M | 320 M | 331 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
45.1 M | 48.9 M | 51.8 M | 60.3 M | 76.3 M | 99.4 M | 113 M | 123 M | 89 M | 69.7 M | 58.6 M | 61.6 M | 5.05 M | 17 M | 29.4 M | 56.2 M | 22.8 M | 19.9 M | 25.8 M | 71.3 M | 107 M | 153 M | 206 M | 125 M | 166 M | 206 M | 240 M | 267 M | 288 M | 312 M | 322 M | -7.75 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
45.1 M | 48.9 M | 51.8 M | 60.3 M | 76.3 M | 99.4 M | 113 M | 113 M | 89 M | 89 M | 69.7 M | 58.6 M | 5.05 M | 5.05 M | 29.4 M | 29.4 M | 22.8 M | 22.8 M | 19.9 M | 71.3 M | 107 M | 153 M | 206 M | 125 M | 166 M | 206 M | 240 M | 267 M | 288 M | 312 M | 322 M | -7.75 M | -5.76 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung